share_log

Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year Low at $49.81

Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year Low at $49.81

威望消费者医疗保健(纽约证券交易所代码：PBH)跌至49.81美元的一年新低
Financial News Live ·  2022/09/22 12:51

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price hit a new 52-week low during trading on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares. The stock had previously closed at $50.55.

威望消费者医疗保健公司(纽约证券交易所代码：PBH-GET Rating)的股价在周四的交易中创下52周来的新低。该公司股价一度跌至49.81美元，最新报49.81美元，成交量为18股。此前该股收盘价为50.55美元。

Analysts Set New Price Targets

分析师设定新的价格目标

Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.

另外，DA Davidson在8月9日(星期二)的一份报告中重申了对Prestige Consumer Healthcare股票的“中性”评级。两名股票研究分析师对该股的评级为持有，三名分析师对该公司股票的评级为买入。根据MarketBeat.com的数据，该股目前的共识评级为“适度买入”，共识目标价为80.50美元。

Get
到达
Prestige Consumer Healthcare
威望消费者医疗保健
alerts:
警报：

Prestige Consumer Healthcare Price Performance

威望消费者医疗保健价格表现

The company has a current ratio of 2.09, a quick ratio of 1.23 and a debt-to-equity ratio of 0.93. The firm has a market cap of $2.50 billion, a PE ratio of 12.67, a price-to-earnings-growth ratio of 1.51 and a beta of 0.55. The stock has a 50 day simple moving average of $55.44 and a 200-day simple moving average of $55.50.

该公司的流动比率为2.09，速动比率为1.23，债务权益比率为0.93。该公司市值为25亿美元，市盈率为12.67倍，市盈率为1.51倍，贝塔系数为0.55。该股的50日简单移动均线切入位为55.44美元，200日简单移动均线切入位为55.50美元。

Institutional Investors Weigh In On Prestige Consumer Healthcare

机构投资者看好Prestige Consumer Healthcare

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock worth $482,584,000 after buying an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock worth $294,322,000 after buying an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Prestige Consumer Healthcare by 0.4% during the first quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp grew its position in shares of Prestige Consumer Healthcare by 4.9% during the second quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. grew its position in shares of Prestige Consumer Healthcare by 4.4% during the second quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. Hedge funds and other institutional investors own 99.37% of the company's stock.
一些机构投资者最近买卖了该公司的股票。贝莱德股份有限公司在第一季度增持了Prestige Consumer Healthcare 12.4%的股份。贝莱德股份有限公司现在持有该公司9,115,718股股票，价值482,584,000美元，该公司在上个季度又购买了1,004,337股。先锋集团第一季度增持Prestige Consumer Healthcare股份1.1%。先锋集团目前持有该公司5,559,553股股票，价值294,322,000美元，上一季度又购买了59,740股。Dimension Fund Advisors LP在第一季度将其在Prestige Consumer Healthcare的股票头寸增加了0.4%。Dimension Fund Advisors LP现在拥有该公司3,448,246股股票，价值182,552,000美元，上个季度又购买了12,790股。道富集团在第二季度持有的Prestige Consumer Healthcare股票增加了4.9%。道富银行目前持有1,921,456股该公司股票，价值112,982,000美元，上一季度又购买了89,131股。最后，麦格理集团第二季度增持Prestige Consumer Healthcare股票4.4%。麦格理集团目前持有该公司1,887,479股股票，价值110,984,000美元，上一季度又购买了79,519股。对冲基金和其他机构投资者持有该公司99.37%的股票。

About Prestige Consumer Healthcare

关于Prestige Consumer Healthcare

(Get Rating)

(获取评级)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

威望消费者保健公司及其子公司在美国和国际上开发、制造、营销、分销和销售非处方药(OTC)健康和个人护理产品。该公司在北美OTC Healthcare和国际OTC Healthcare两个部门运营。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免费获取StockNews.com关于Prestige Consumer Healthcare(PBH)的研究报告
  • 这些机构持有达顿餐饮国际公司的股份
  • 斯蒂尔凯斯的收益说明了他重返办公室的原因吗？
  • 住房建设的黄金时代已经结束了吗？
  • 这三大股利支付者也拥有强劲的价格增长
  • 天然气价格继续回升，这些股票应该会受益

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

获得《尊贵消费者保健日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Prestige Consumer Healthcare和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发